Cargando…
The Role of Human Beta-Defensin-2 in Pseudomonas aeruginosa Pulmonary Infection in Cystic Fibrosis Patients
Cystic fibrosis (CF) is the most common genetic disease affecting the Caucasian population. Chronic Pseudomonas aeruginosa pulmonary infection is the major cause of morbidity and mortality in CF patients. Human beta-defensin-2 (hBD-2) is an inducible pulmonary antimicrobial peptide that exerts bacte...
Autores principales: | Dalcin, Daniel, Ulanova, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108104/ https://www.ncbi.nlm.nih.gov/pubmed/25134478 http://dx.doi.org/10.1007/s40121-013-0015-5 |
Ejemplares similares
-
Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis
por: Sordé, Roger, et al.
Publicado: (2011) -
Cystic fibrosis lung environment and Pseudomonas aeruginosa infection
por: Bhagirath, Anjali Y., et al.
Publicado: (2016) -
Differential regulation of interleukin-8 and human beta-defensin 2 in Pseudomonas aeruginosa-infected intestinal epithelial cells
por: Huang, Fu-Chen
Publicado: (2014) -
Porphyromonas, a potential predictive biomarker of Pseudomonas aeruginosa pulmonary infection in cystic fibrosis
por: Keravec, Marlène, et al.
Publicado: (2019) -
Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
por: Høiby, Niels
Publicado: (2011)